Profit with us in the 2009 bear market
   

Recent Material Events - Immunomedics, Inc (IMMU)

Filing Date Description
2009-11-06 On November 6, 2009, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release to report the Company's financial results for the quarter ended September 30, 2009. The full text of the press release is attached to this current ...
2009-10-15 On October 15, 2009, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release announcing further topline results for epratuzumab Phase IIb study in systemic lupus erythematosus (SLE). The full text of the press release is at ...
2009-08-27 Information required to be disclosed by this Item about the Section 16(a) compliance of our directors and executive officers is incorporated in this annual report on Form 10-K by reference from the section entitled “Section 16(a) Beneficial Owne ...
2009-08-27 On August 27, 2009, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release to report the Company's financial results for the fiscal year ended and quarter ended June 30, 2009. The full text of the press release is attached ...
2009-08-07 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2009-06-16 In connection with its annual review of executive compensation, on June 10, 2009, the Compensation Committee of the Board of Directors of Immunomedics, Inc., a Delaware corporation (the “Company”), approved the following annual base salarie ...
2009-05-11 On May 11, 2009, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release to report the Company's financial results for the quarter ended March 31, 2009. The full text of the press release is attached to this current report ...
2009-02-09 On February 9, 2009, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release to report the Company's financial results for the quarter ended December 31, 2008. The full text of the press release is attached to this current ...
2008-12-22 Section 409A changed the income tax treatment of nonqualified deferred compensation and imposed new requirements on both the terms and operation of such compensation. Although Section 409A’s provisions have been in effect since 2005 and employer ...
2008-12-03 On December 3, 2008, Immunomedics, Inc., a Delaware corporation (the "Company"), issued a press release announcing that stockholders of the Company, at its 25th annual meeting (the "Annual Meeting"), elected all seven nominees to serve as directors o ...
   
 
Home > Companies > Immunomedics, Inc > Recent Material Events
Home | Message boards | Newsletters | Latest Comments | AIM London Stock Exchange | Canadian stocks | Chinese stocks
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2009 hotstocked.com - All rights reserved.